Levodopa therapy can ameliorate tetrabenazine-induced parkinsonism

Mov Disord. 1999 Jan;14(1):158-9. doi: 10.1002/1531-8257(199901)14:1<158::aid-mds1028>3.0.co;2-q.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antiparkinson Agents / therapeutic use*
  • Blepharospasm / drug therapy
  • Dyskinesia, Drug-Induced / diagnosis
  • Dyskinesia, Drug-Induced / drug therapy
  • Female
  • Humans
  • Levodopa / therapeutic use*
  • Middle Aged
  • Neurologic Examination / drug effects
  • Parkinson Disease, Secondary / chemically induced*
  • Parkinson Disease, Secondary / drug therapy
  • Recurrence
  • Sulpiride / administration & dosage
  • Sulpiride / adverse effects
  • Tetrabenazine / administration & dosage
  • Tetrabenazine / adverse effects*

Substances

  • Antiparkinson Agents
  • Levodopa
  • Sulpiride
  • Tetrabenazine